Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya
نویسندگان
چکیده
منابع مشابه
Cost effectiveness of child pneumococcal conjugate vaccination in GAVI-eligible countries.
Policy-makers increasingly rely on cost-effectiveness analysis, in addition to clinical effectiveness, when considering the introduction of new childhood vaccines. A previous analysis determined vaccination of infants with 7-valent pneumococcal conjugate vaccine (PCV) to be highly cost effective in preventing child mortality in countries eligible for financial support from the Global Alliance f...
متن کاملA Case Study: Cost--effectiveness Analysis of Vaccination against Pneumococcal Pneumonia a Case Study: Cost-effectiveness Analysis of Vaccination against Pneumococcal Pneumonia
These modes of analysis [cost-effectiveness and cost-benefit] are neither good for nothing nor good for everything, and one cannot speak of them as wholly good or bad. It is much more useful to try to specify some conditions under which they would or would not be helpful for various purposes.
متن کاملCost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia
OBJECTIVE The Ministry of Health (MOH), Mongolia, is considering introducing 13-valent pneumococcal conjugate vaccine (PCV13) in its national immunization programme to prevent the burden of disease caused by Streptococcus pneumoniae. This study evaluates the cost-effectiveness and budget impact of introducing PCV13 compared to no PCV vaccination in Mongolia. METHODS The incremental cost-effec...
متن کاملEstimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil.
OBJECTIVE To compare the costs and benefits of pneumococcal conjugate vaccination compared with no vaccination from the perspectives of the health care system and society. METHODS Using data from established sources, we estimated the incidence and mortality due to invasive pneumococcal disease, pneumonia, and acute otitis media (AOM) for a hypothetical birth cohort of children from birth to 5...
متن کاملCost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
The Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) demonstrated the efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in preventing vaccine-type community-acquired pneumonia and vaccine-type invasive pneumococcal disease in elderly subjects. We examined the cost-effectiveness of PCV13 vaccination in the Netherlands. Using a Markov-type model, incremental cost-effe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet Global Health
سال: 2019
ISSN: 2214-109X
DOI: 10.1016/s2214-109x(18)30562-x